Table 1 Correlation of the clinicopathologic features and ascites Cyr61 level of ovarian serous adenocarcinoma
Clinicopathologic factors | Categorization | Number (%) | Cyr61 (pg/ml) | P value |
|---|---|---|---|---|
FIGO stage | I-II | 14 (21.1) | 698.74 ± 87.12 | 0.001 |
III-IV | 52 (78.9) | 2054.23 ± 132.09* | ||
Initial tumor size (cm) | < 10 | 45 (68.2) | 910.81 ± 98.31 | 0.002 |
≥10 | 21 (31.8) | 2125.66 ± 154.38* | ||
Ascites volume (ml) | < 500 | 9 (13.6) | 1416.41 ± 102.37 | 0.124 |
≥500 | 57 (86.4) | 1760.65 ± 154.64 | ||
Residual tumor (cm) | < 1 | 54 (81.8) | 1031.64 ± 78.31 | 0.025 |
≥1 | 12 (18.2) | 2097.30 ± 174.69* | ||
Lymphatic invasion | – | 60 (90.9) | 1936.22 ± 191.37 | 1.475 |
+ | 6 (9.1) | 2128.37 ± 478.26 | ||
Vascular invasion | – | 62 (93.9) | 2117.11 ± 201.39 | 1.756 |
+ | 4 (6.1) | 2403.74 ± 345.21 | ||
Ascites tumor cells | – | 57 (86.4) | 1613.62 ± 119.27 | 0.124 |
+ | 9 (13.6) | 1736.28 ± 114.30 |